Travere Therapeutics, Inc. financial data

Symbol
TVTX on Nasdaq
Location
3611 Valley Centre Dr, Suite 300, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % -19.5%
Quick Ratio 21.9 % +5.49%
Debt-to-equity 1.03K % +18.7%
Return On Equity -179 % +67%
Return On Assets -15.8 % +71.8%
Operating Margin -20.9 % +88.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89.5M shares +14.6%
Common Stock, Shares, Outstanding 89.5M shares +14.8%
Entity Public Float 624M USD -45.5%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 89.2M shares +14.7%
Weighted Average Number of Shares Outstanding, Diluted 103M shares +31.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 436M USD +114%
Research and Development Expense 7.5M USD
Costs and Expenses 527M USD -6.03%
Operating Income (Loss) -91.1M USD +74.5%
Nonoperating Income (Expense) 2.58M USD -70.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -88.5M USD +74.6%
Income Tax Expense (Benefit) -5K USD -102%
Net Income (Loss) Attributable to Parent -88.5M USD +74.8%
Earnings Per Share, Basic -1 USD/shares +77.4%
Earnings Per Share, Diluted -1 USD/shares +77.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 111M USD +205%
Accounts Receivable, after Allowance for Credit Loss, Current 83M USD +230%
Inventory, Net 37.5M USD -12.4%
Assets, Current 371M USD +14.3%
Property, Plant and Equipment, Net 4.32M USD -29.9%
Operating Lease, Right-of-Use Asset 11.5M USD -26.8%
Intangible Assets, Net (Excluding Goodwill) 109M USD +5.02%
Goodwill 800K USD 0%
Other Assets, Noncurrent 10.3M USD -40.1%
Assets 539M USD +6.77%
Accounts Payable, Current 18.2M USD -21.4%
Accrued Liabilities, Current 106M USD +26%
Contract with Customer, Liability, Current 2.82M USD -60.3%
Liabilities, Current 135M USD -28.9%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 12.6M USD -31.9%
Other Liabilities, Noncurrent 5.93M USD -63.6%
Liabilities 465M USD -13.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.05M USD -3.74%
Retained Earnings (Accumulated Deficit) -1.48B USD -6.38%
Stockholders' Equity Attributable to Parent 73.6M USD
Liabilities and Equity 539M USD +6.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42.2M USD +64.5%
Net Cash Provided by (Used in) Financing Activities 3.72M USD
Net Cash Provided by (Used in) Investing Activities 41.3M USD -60.6%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 89.5M shares +14.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.36M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 111M USD +205%
Deferred Tax Assets, Valuation Allowance 344M USD +18.4%
Deferred Tax Assets, Gross 349M USD +17.6%
Operating Lease, Liability 18.4M USD -23%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -88.6M USD +74.6%
Lessee, Operating Lease, Liability, to be Paid 20.2M USD -25.4%
Property, Plant and Equipment, Gross 14.1M USD -5.57%
Operating Lease, Liability, Current 5.73M USD +8.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.98M USD +1.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.78M USD +1.53%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.81M USD -43.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.78M USD -32.3%
Deferred Tax Assets, Operating Loss Carryforwards 113M USD +39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 27.4M USD +19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.78M USD -32.3%
Additional Paid in Capital 1.55B USD +14.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 53.1M USD +36.2%
Depreciation, Depletion and Amortization 12.8M USD +29.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 42.6M USD +18.9%
Interest Expense 11.2M USD -1.75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%